Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOC-201 in Elective PCI for Acute Coronary Syndromes
NCT00317512Phase 2Completed
- Sponsor
- Biopure
- Start
- Dec 2003
- Primary completion
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of hemoglobin glutamer-250 in acute coronary syndrome (ACS), sponsored by Biopure. Started Dec 2003; status: completed.
02
Drugs
hemoglobin glutamer-250
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00317512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317512.